Medical Market Report

Global e-Clinical Trial Technologies Market By Type (Clinical Analytics Platforms, Electronic Data Capture (EDC), Clinical Data Management Systems (CDMS), Randomization & Trial Supply Management (RTSM), Electronic Clinical Outcome Assessment (ECOA), Clinical Data Integration Platforms, Clinical Trial Management Systems (CTMS), and Electronic Trial Master File (eTMF)), By Application (Medical Laboratory, Hospitals, and Pharmaceutical Companies), By Region, and Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2020-2029

  • 138640
  • 18-Dec
  • PDF/PPT/Word
  • ★ ★ ★ ★ ★
    ★ ★ ★ ★ ★
  • Report Details

    Global e-Clinical Trial Technologies Market is estimated to be valued US$ XX.X million in 2019. The report on e-Clinical Trial Technologies Market provides qualitative as well as quantitative analysis in terms of market dynamics, competition scenarios, opportunity analysis, market growth, etc. for the forecast year up to 2029. The global e-clinical trial technologies market is segmented on the basis of Type, Application, and geography.

    In 2019, the North America market is valued US$ XX.X million and the market share is estimated X.X%, and it is expected to be US$ XX.X million and X.X% in 2029, with a CAGR X.X% from 2020 to 2029.

    e-Clinical Trial Technologies Market Scope:

    By type, the market is segmented into Clinical Analytics Platforms, Electronic Data Capture (EDC), Clinical Data Management Systems (CDMS), Randomization & Trial Supply Management (RTSM), Electronic Clinical Outcome Assessment (ECOA), Clinical Data Integration Platforms, Clinical Trial Management Systems (CTMS), and Electronic Trial Master File (eTMF). By Application, the market is divided into Medical Laboratory, Hospitals, and Pharmaceutical Companies.
    Based on geography, the market is analyzed across North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa. Major players profiled in the report include BioClinica, PAREXEL, EClinical Solutions, Ecrfplus, Clincase, Merge, Oracle, Medidata Solutions, Clinpal, NTT DATA, DATATRAK, Omnicomm, MedNet Solutions, Prelude Dynamics, Nextrials, DSG, DZS, EClinForce, Almac, and ArisUSA.

    Key Market Segments

    Type

    Clinical Analytics Platforms

    Electronic Data Capture (EDC)

    Clinical Data Management Systems (CDMS)

    Randomization & Trial Supply Management (RTSM)

    Electronic Clinical Outcome Assessment (ECOA)

    Clinical Data Integration Platforms

    Clinical Trial Management Systems (CTMS)

    Electronic Trial Master File (eTMF)

    Application

    Medical Laboratory

    Hospitals

    Pharmaceutical Companies

    Key Market Players included in the report:

    BioClinica

    PAREXEL

    EClinical Solutions

    Ecrfplus

    Clincase

    Merge

    Oracle

    Medidata Solutions

    Clinpal

    NTT DATA

    DATATRAK

    Omnicomm

    MedNet Solutions

    Prelude Dynamics

    Nextrials

    DSG

    DZS

    EClinForce

    Almac

    ArisUSA

    Reasons to Get this Report:

    In an insight outlook, this research report has dedicated to several quantities of analysis – industry research (global industry trends) and e-Clinical Trial Technologies Market share analysis of high players, along with company profiles, and which collectively include about the fundamental opinions regarding the market landscape; emerging and high-growth sections of e-Clinical Trial Technologies Market; high-growth regions; and market drivers, restraints, and also market chances.
    The analysis covers e-Clinical Trial Technologies Market and its advancements across different industry verticals as well as regions. It targets estimating the current market size and growth potential of the global e-Clinical Trial Technologies Market across sections such as also Application and representatives.
    Additionally, the analysis also has a comprehensive review of the crucial players on the e-Clinical Trial Technologies Market together side their company profiles, SWOT analysis, latest advancements, and business plans.

    The analysis objectives of the report are:

    To equitably share in-depth info regarding the crucial elements impacting the increase of industry (growth capacity, chances, drivers, and industry-specific challenges and risks).
    To know the e-Clinical Trial Technologies Market by pinpointing its many subsegments.
    To profile the important players and analyze their growth plans.
    To endeavor the amount and value of e-Clinical Trial Technologies sub-markets, depending on key regions (various vital states).
    To analyze e-Clinical Trial Technologies Market concerning growth trends, prospects, and also their participation in the entire sector.
    To examine and study the e-Clinical Trial Technologies Market size (volume & value) from the company, essential regions/countries, products, and Application, background information from 2013 to 2018, and also prediction to 2029.
    Primary worldwide e-Clinical Trial Technologies Market manufacturing companies, to specify, clarify and analyze the product sales amount, value and market share, market rivalry landscape, SWOT analysis and development plans next coming years.
    To examine competitive progress such as expansions, arrangements, new product launches, and acquisitions on the market.

  • Table Of Content 
    1. e-Clinical Trial Technologies Market Introduction
    

    1.1. Definition
    
1.2. Taxonomy
    
1.3. Research Scope
    

    2. Executive Summary
    

      2.1. Key Findings by Major Segments
    
  2.2. Top strategies by Major Players
    

    3. Global e-Clinical Trial Technologies Market Overview
    

    3.1. e-Clinical Trial Technologies Market Dynamics
    

        3.1.1. Drivers
    
    3.1.2. Opportunities
    
    3.1.3. Restraints
    
    3.1.4. Challenges
    

      3.2. PESTLE Analysis
    
  3.3. Opportunity Map Analysis
    
  3.4. PORTER’S Five Forces Analysis
    
  3.5. Market Competition Scenario Analysis
    
  3.6. Product Life Cycle Analysis
    
  3.7. Opportunity Orbits
    
  3.8. Production Analysis by Region/Company
    
  3.9. Industry chain Analysis
    
  3.10. Marketing Strategy
    

    4. Global e-Clinical Trial Technologies Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Type, 2012-2028
    

      4.1. Global e-Clinical Trial Technologies Market Analysis by Type: Introduction
    
  4.2. Market Size and Forecast by Region
    
  4.3. Clinical Analytics Platforms
    

      4.4. Electronic Data Capture (EDC)
    

      4.5. Clinical Data Management Systems (CDMS)
    

      4.6. Randomization & Trial Supply Management (RTSM)
    

      4.7. Electronic Clinical Outcome Assessment (ECOA)
    

      4.8. Clinical Data Integration Platforms
    

      4.9. Clinical Trial Management Systems (CTMS)
    

      4.10. Electronic Trial Master File (eTMF)
    

    5. Global e-Clinical Trial Technologies Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Application, 2012-2028
    

      5.1. Global e-Clinical Trial Technologies Market Analysis by Application: Introduction
    
  5.2. Market Size and Forecast by Region
    
  5.3. Medical Laboratory
    

      5.4. Hospitals
    

      5.5. Pharmaceutical Companies
    

    6. Global e-Clinical Trial Technologies Market Value & Volume ((US$ Mn & ‘000 Units)), Share (%), and Growth Rate (%) Comparison by Region, 2012-2028
    

      6.1. North America
    

        6.1.1. North America e-Clinical Trial Technologies Market: Regional Trend Analysis
    

         6.1.1.1. US
    
     6.1.1.2. Canada
    
     6.1.1.3. Mexico
    

      6.2.1. Europe
    

        6.2.1. Europe e-Clinical Trial Technologies Market: Regional Trend Analysis
    

         6.2.1.1. Germany
    
     6.2.1.2. France
    
     6.2.1.3. UK
    
     6.2.1.4. Russia
    
     6.2.1.5. Italy
    
     6.2.1.6. Spain
    
     6.2.1.7. Rest of Europe
    

      6.3. Asia-Pacific
    

        6.3.1. Asia-Pacific e-Clinical Trial Technologies Market: Regional Trend Analysis
    

         6.3.1.1. China
    
     6.3.1.2. Japan
    
     6.3.1.3. Korea
    
     6.3.1.4. India
    
     6.3.1.5. Rest of Asia-Pacific
    

      6.4. Latin America
    

        6.4.1. Latin America e-Clinical Trial Technologies Market: Regional Trend Analysis
    

         6.4.1.1. Brazil
    
     6.4.1.2. Argentina
    
     6.4.1.3. Rest of Latin America
    

      6.5. Middle East and Africa
    

        6.5.1. Middle East and Africa e-Clinical Trial Technologies Market: Regional Trend Analysis
    

         6.5.1.1. GCC
    
     6.5.1.2. South Africa
    
     6.5.1.3. Israel
    
     6.5.1.4. Rest of MEA
    

    7. Global e-Clinical Trial Technologies Market Competitive Landscape, Market Share Analysis, and Company Profiles
    

      7.1. Market Share Analysis
    
  7.2. Company Profiles
    
  7.3. BioClinica
    

        7.3.1. Company Overview
    
    7.3.2. Financial Highlights
    
    7.3.3. Product Portfolio
    
    7.3.4. SWOT Analysis
    
    7.3.5. Key Strategies and Developments
    

      7.4. PAREXEL
    

        7.4.1. Company Overview
    
    7.4.2. Financial Highlights
    
    7.4.3. Product Portfolio
    
    7.4.4. SWOT Analysis
    
    7.4.5. Key Strategies and Developments
    

      7.5. EClinical Solutions
    

        7.5.1. Company Overview
    
    7.5.2. Financial Highlights
    
    7.5.3. Product Portfolio
    
    7.5.4. SWOT Analysis
    
    7.5.5. Key Strategies and Developments
    

      7.6. Ecrfplus
    

        7.6.1. Company Overview
    
    7.6.2. Financial Highlights
    
    7.6.3. Product Portfolio
    
    7.6.4. SWOT Analysis
    
    7.6.5. Key Strategies and Developments
    

      7.7. Clincase
    

        7.7.1. Company Overview
    
    7.7.2. Financial Highlights
    
    7.7.3. Product Portfolio
    
    7.7.4. SWOT Analysis
    
    7.7.5. Key Strategies and Developments
    

      7.8. Merge
    

        7.8.1. Company Overview
    
    7.8.2. Financial Highlights
    
    7.8.3. Product Portfolio
    
    7.8.4. SWOT Analysis
    
    7.8.5. Key Strategies and Developments
    

      7.9. Oracle
    

        7.9.1. Company Overview
    
    7.9.2. Financial Highlights
    
    7.9.3. Product Portfolio
    
    7.9.4. SWOT Analysis
    
    7.9.5. Key Strategies and Developments
    

      7.10. Medidata Solutions
    

        7.10.1. Company Overview
    
    7.10.2. Financial Highlights
    
    7.10.3. Product Portfolio
    
    7.10.4. SWOT Analysis
    
    7.10.5. Key Strategies and Developments
    

      7.11. Clinpal
    

        7.11.1. Company Overview
    
    7.11.2. Financial Highlights
    
    7.11.3. Product Portfolio
    
    7.11.4. SWOT Analysis
    
    7.11.5. Key Strategies and Developments
    

      7.12. NTT DATA
    

        7.12.1. Company Overview
    
    7.12.2. Financial Highlights
    
    7.12.3. Product Portfolio
    
    7.12.4. SWOT Analysis
    
    7.12.5. Key Strategies and Developments
    

      7.13. DATATRAK
    

        7.13.1. Company Overview
    
    7.13.2. Financial Highlights
    
    7.13.3. Product Portfolio
    
    7.13.4. SWOT Analysis
    
    7.13.5. Key Strategies and Developments
    

      7.14. Omnicomm
    

        7.14.1. Company Overview
    
    7.14.2. Financial Highlights
    
    7.14.3. Product Portfolio
    
    7.14.4. SWOT Analysis
    
    7.14.5. Key Strategies and Developments
    

      7.15. MedNet Solutions
    

        7.15.1. Company Overview
    
    7.15.2. Financial Highlights
    
    7.15.3. Product Portfolio
    
    7.15.4. SWOT Analysis
    
    7.15.5. Key Strategies and Developments
    

      7.16. Prelude Dynamics
    

        7.16.1. Company Overview
    
    7.16.2. Financial Highlights
    
    7.16.3. Product Portfolio
    
    7.16.4. SWOT Analysis
    
    7.16.5. Key Strategies and Developments
    

      7.17. Nextrials
    

        7.17.1. Company Overview
    
    7.17.2. Financial Highlights
    
    7.17.3. Product Portfolio
    
    7.17.4. SWOT Analysis
    
    7.17.5. Key Strategies and Developments
    

      7.18. DSG
    

        7.18.1. Company Overview
    
    7.18.2. Financial Highlights
    
    7.18.3. Product Portfolio
    
    7.18.4. SWOT Analysis
    
    7.18.5. Key Strategies and Developments
    

      7.19. DZS
    

        7.19.1. Company Overview
    
    7.19.2. Financial Highlights
    
    7.19.3. Product Portfolio
    
    7.19.4. SWOT Analysis
    
    7.19.5. Key Strategies and Developments
    

      7.20. EClinForce
    

        7.20.1. Company Overview
    
    7.20.2. Financial Highlights
    
    7.20.3. Product Portfolio
    
    7.20.4. SWOT Analysis
    
    7.20.5. Key Strategies and Developments
    

      7.21. Almac
    

        7.21.1. Company Overview
    
    7.21.2. Financial Highlights
    
    7.21.3. Product Portfolio
    
    7.21.4. SWOT Analysis
    
    7.21.5. Key Strategies and Developments
    

      7.22. ArisUSA
    

        7.22.1. Company Overview
    
    7.22.2. Financial Highlights
    
    7.22.3. Product Portfolio
    
    7.22.4. SWOT Analysis
    
    7.22.5. Key Strategies and Developments
    

    8. Assumptions and Acronyms
    
9. Research Methodology
    
10. Contact
  • Inquiry Before Buying

    Inquiry Form

  • Request Sample

    Request for Sample

Related Reports

Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.